| Megan Brinker, | |
|
1744 Payne Ave, Cleveland, OH 44114-2910 | |
| (216) 361-8640 | |
| (216) 361-8646 |
| Full Name | Megan Brinker |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1744 Payne Ave, Cleveland, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023463593 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | I.1201302 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Brinker, 1744 Payne Ave, Cleveland, OH 44114-2910 Ph: (216) 361-8640 | Megan Brinker, 1744 Payne Ave, Cleveland, OH 44114-2910 Ph: (216) 361-8640 |
News Archive
Neuroinflammation is the key driver of the spread of pathologically misfolded proteins in the brain and causes cognitive impairment in patients with Alzheimer's disease, researchers from the University of Pittsburgh School of Medicine reveal in a paper published today in Nature Medicine.
An examination of process measures endorsed by the National Quality Forum finds that these measures focus predominantly on management of patients with established diagnoses, and that quality measures for patient presenting symptoms often do not reflect the most common reasons patients seek care, according to a study in the February 3 issue of JAMA.
Women who use electronic cigarettes during pregnancy are 33% more likely than those who don't to give birth to low-birthweight infants, according to a new study by a team of researchers from UCLA and other institutions.
Opening up a can of worms is a good way to start hunting for new drugs, recommend researchers from Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine.
Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT) products for cancer, today announced that the U.S. Food and Drug Administration Office of Orphan Products Development granted orphan drug designation for the Company's lead investigational therapy, an autologous engineered T cell product that targets CD19 expression on B cell malignancies, for the treatment of diffuse large B cell lymphoma (DLBCL).
› Verified 4 days ago
Claudette M Williams, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5500 S Marginal Rd, Cleveland, OH 44103 Phone: 216-221-7588 | |
Sherah Ytta Newman, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12201 Euclid Ave, Cleveland, OH 44106 Phone: 216-707-3469 Fax: 216-707-3529 | |
Jacqueline H Goodin, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3430 Rocky River Dr, Cleveland, OH 44111 Phone: 216-688-1111 Fax: 216-251-2886 | |
Jillian Bertoncin, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11801 Buckeye Rd, Cleveland, OH 44120 Phone: 216-831-2255 Fax: 216-378-3906 | |
Mrs. Mervat M Khafaga, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4115 Bridge Ave, Cleveland, OH 44113 Phone: 216-631-5800 Fax: 216-631-4595 | |
Ruth Sudilovsky-pecha, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 526 Superior Ave E, #1400, Cleveland, OH 44114 Phone: 216-619-6194 | |
Ms. Charlotte Drema Slade, MSW, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 966 E 146th St, Cleveland, OH 44110 Phone: 216-851-1853 |